Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the bone and mineral diagnostic testing market?
In the past few years, the market for bone and mineral diagnostic testing has seen consistent growth. It is expected to increase from $1.09 billion in 2024 to $1.14 billion in 2025, with a compound annual growth rate (CAGR) of 4.9%. The growth observed during the historical period is due to factors including the needs of an aging population, the prevalence of osteoporosis, initiatives in awareness and education, the clinical necessity of monitoring, and the assessment of fracture risk.
What will be the bone and mineral diagnostic testing market size in the future?
Anticipated to experience robust growth in the forthcoming years, the bone and mineral diagnostic testing market is set to expand to “$1.42 billion by 2029, boasting a compound annual growth rate (CAGR) of 5.6%. The predicted expansion during this period is largely due to the progression in diagnostic technologies, rising occurrence of metabolic bone disorders, heightened focus on preventative health measures, and alignment with personalized medicine strategies. Noteworthy trends projected for this period include the incorporation of biochemical markers, telehealth and distance monitoring, growth of home-based testing kits, cooperative efforts in research and innovation, and a comprehensive approach to diagnostic panels.
Get your bone and mineral diagnostic testing market report here!
What main drivers are fueling expansion in the bone and mineral diagnostic testing market?
The rising prevalence of bone disorders is anticipated to drive the expansion of the bone and mineral diagnostic testing industry. Conditions that impact the robustness or resilience of bones are considered bone diseases, making bones more susceptible to fractures. These could manifest in symptoms such as bone discomfort, mobility issues, and a heightened likelihood of bone fractures. Bone and mineral diagnostic evaluations, like bone density tests, are instrumental in thwarting bone diseases by identifying deficiencies in bone density prior to the development of osteoporosis, predicting potential future fractures, and monitoring the effectiveness of current osteoporosis treatments. The growth of the bone and mineral diagnostic testing sector is likely to be fueled by the escalating occurrence of bone diseases, enhanced awareness, and technological progress. For example, The National Center for Biotechnology Information (NCBI), a governmental agency based in the U.S., stated in May 2022 that the primary concern of osteoporosis is fractures, with future estimates indicating a 310% and 240% surge in global hip fractures among men and women respectively by 2050. Consequently, the intensifying frequency of bone-related diseases will spur the growth of the bone and mineral diagnostic testing sector.
What key areas define the segmentation of the global bone and mineral diagnostic testing market?
The bone and mineral diagnostic testing market covered in this report is segmented –
1) By Product: Assays Or Consumables, Instruments
2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types
3) By Application: Vitamin D Testing, Bone Metabolism
Subsegments:
1) By Assays Or Consumables: Bone Turnover Markers Assays, Vitamin D Assays, Calcium And Phosphate Assays, Sample Collection Kits, Reagents And Standards
2) By Instruments: Bone Densitometers, X-Ray Machines, Ultrasound Devices, MRI Machines, Other Diagnostic Instruments
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10731&type=smp
Who are the dominant players expanding their reach in the bone and mineral diagnostic testing market?
Major companies operating in the bone and mineral diagnostic testing market include Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Beammed Ltd., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Medonica Co. Ltd., Epitope Diagnostics Inc., Alere Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences lnc., Medtronic plc, Thermo Fisher Scientific lnc., Sysmex Corporation, EKF Diagnostics, Bruker Corporation, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Waters Corporation, Danaher Corporation, Merck KGaA
How are evolving market trends shaping bone and mineral diagnostic testing Strategies?
The bone and mineral diagnostic testing market is seeing a rising trend in the form of technological innovations. Market players in this sector are utilizing new technology to maintain their standing in the market. In May 2022, the American medical technology firm, GE HealthCare Technologies Inc., came up with a cutting-edge MRI procedure that utilizes unique pulse sequences like zero echo time (ZTE) for viewing tendons, ligaments, calcium deposits, and cortical bone structures. This breakthrough in MR bone imaging offers a CT-like image contrast in 3D isotropic resolution, all while avoiding exposing the patient to any ionizing radiation. Currently, it’s being employed to garner morphological data about cortical bone structure in anatomical builds like the shoulder, hip, skull, foot or ankle, and spine. This method’s potential is particularly noteworthy for longitudinal CTs, especially when low-dose CTs are not available.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10731
Which regions are emerging as leaders in the bone and mineral diagnostic testing market?
North America was the largest region in the bone and mineral diagnostic testing market in 2024. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Facial Tissues Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/facial-tissues-global-market-report
Prosthetic Heart Valve Devices And Equipment Global Market Report 2024
Biotechnology Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/biotechnology-services-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
